Federated Hermes’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.1M | Sell |
936,981
-267,146
| -22% | -$4.86M | 0.03% | 462 |
|
|
2025
Q1 | $23.9M | Sell |
1,204,127
-102,809
| -8% | -$2.04M | 0.05% | 369 |
|
|
2024
Q4 | $22.4M | Sell |
1,306,936
-320,757
| -20% | -$5.5M | 0.05% | 388 |
|
|
2024
Q3 | $32.5M | Sell |
1,627,693
-342,118
| -17% | -$6.84M | 0.07% | 321 |
|
|
2024
Q2 | $22M | Buy |
1,969,811
+263,677
| +15% | +$2.95M | 0.05% | 385 |
|
|
2024
Q1 | $11.3M | Buy |
1,706,134
+899,122
| +111% | +$5.93M | 0.03% | 543 |
|
|
2023
Q4 | $3.65M | Buy |
807,012
+33,767
| +4% | +$153K | 0.01% | 796 |
|
|
2023
Q3 | $2.77M | Buy |
773,245
+111,631
| +17% | +$400K | 0.01% | 837 |
|
|
2023
Q2 | $2.44M | Sell |
661,614
-250,348
| -27% | -$924K | 0.01% | 891 |
|
|
2023
Q1 | $3.02M | Buy |
911,962
+420,310
| +85% | +$1.39M | 0.01% | 832 |
|
|
2022
Q4 | $1.91M | Buy |
491,652
+165,540
| +51% | +$642K | 0.01% | 925 |
|
|
2022
Q3 | $793K | Buy |
+326,112
| New | +$793K | ﹤0.01% | 1199 |
|
|
2020
Q1 | – | Sell |
-22,825
| Closed | -$91K | – | 2230 |
|
|
2019
Q4 | $91K | Buy |
+22,825
| New | +$91K | ﹤0.01% | 1684 |
|
|
2018
Q4 | – | Sell |
-309
| Closed | -$2K | – | 2185 |
|
|
2018
Q3 | $2K | Buy |
+309
| New | +$2K | ﹤0.01% | 2134 |
|